📋 BOSTON SCIENTIFIC CORP (BSX) - Clinical Trial Update
Filing Date: 2026-08-26
Accepted: 2026-08-26 06:06:57
Event Type: Clinical Trial Update
Event Details:
BOSTON SCIENTIFIC CORP (BSX) Announces Clinical Trial Update
BOSTON SCIENTIFIC CORP (BSX) provided an update on its clinical development programs.
Clinical Development Highlights:
Update Type: Trial Timeline Adjustment
Primary Factors: Geopolitical Situation, Pandemic-Related Challenges, Regulatory Process
Collaboration: SCIENTIFIC
🔬 Clinical Development Pipeline (BOSTON SCIENTIFIC CORP):
Product
Type
Development Stage
Therapeutic Area
Source
Contak Renewal (CRT-D)
Other
Phase PHASE4
Heart Failure
ClinicalTrials.gov
Renewal TR2
Other
Phase PHASE4
Congestive Heart Failure
ClinicalTrials.gov
Percutaneous Coronary Intervention (PCI)
Other
Phase PHASE2
Coronary Artery Disease
ClinicalTrials.gov
Routine Early Percutaneous Coronary Intervention after Thrombolysis
Other
Approved
Myocardial Infarction
ClinicalTrials.gov
ICD
Other
Phase PHASE4
Ventricular Fibrillation
ClinicalTrials.gov
CRT device
Device
Preclinical
Heart Failure
ClinicalTrials.gov
GUIDANT ICD SYSTEM
Other
Preclinical
Ventricular Fibrillation
ClinicalTrials.gov
Automatic threshold test in Insignia Pacemakers from Guidant
Other
Preclinical
Bradycardia
ClinicalTrials.gov
defibrillation lead (ENDOTAK EZ and RELIANCE)
Other
Preclinical
Sudden Cardiac Death
ClinicalTrials.gov
Temporary RV VVI pacing
Other
Phase PHASE2
Acute Myocardial Infarction
ClinicalTrials.gov
INCEPTA ICD or CRT-D
Other
Preclinical
Sudden Cardiac Death
ClinicalTrials.gov
FineLine II Sterox, FineLine II Sterox, FineLine II Sterox EZ
📋 BOSTON SCIENTIFIC CORP (BSX) - Clinical Trial Update
Filing Date: 2026-08-26
Accepted: 2026-08-26 06:06:57
Event Type: Clinical Trial Update
Event Details:
🔬 Clinical Development Pipeline (BOSTON SCIENTIFIC CORP):
💼 Business Developments:
Structured Data: